Detalhe da pesquisa
1.
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.
Allergy
; 2024 Mar 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38439527
2.
Upadacitinib treatment in a real-world difficult-to-treat atopic dermatitis patient cohort.
J Eur Acad Dermatol Venereol
; 38(2): 384-392, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37864486
3.
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis.
J Eur Acad Dermatol Venereol
; 38(1): 42-51, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37700595
4.
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.
BMC Med
; 20(1): 100, 2022 03 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35236350
5.
Biomarkers in atopic dermatitis-a review on behalf of the International Eczema Council.
J Allergy Clin Immunol
; 147(4): 1174-1190.e1, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33516871
6.
Association between nasal and nasopharyngeal bacterial colonization in early life and eczema phenotypes.
Clin Exp Allergy
; 51(5): 716-725, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33759242
7.
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany.
Emerg Infect Dis
; 26(8): 1935-1937, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32392125
8.
Signal Inhibitory Receptor on Leukocytes-1 is highly expressed on lung monocytes, but absent on mononuclear phagocytes in skin and colon.
Cell Immunol
; 357: 104199, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32942189
9.
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
J Am Acad Dermatol
; 83(5): 1375-1384, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32485210
10.
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Ann Rheum Dis
; 82(6): 883-885, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36720583
11.
Prediction of response to dupilumab treatment.
Br J Dermatol
; 188(6): e41, 2023 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37167296
12.
Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis.
J Allergy Clin Immunol
; 140(3): 730-737, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28412391
13.
Atopic dermatitis: A tale of two distinct pathomechanisms that make you itch.
Eur J Immunol
; 46(11): 2512-2515, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27813070
14.
Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'".
J Am Acad Dermatol
; 85(3): e173-e174, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33675862
15.
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
Allergy
; 75(12): 3287-3289, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33305359
16.
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A.
Allergy
; 74(3): 613-617, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30368864
17.
Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity.
Allergy
; 74(11): 2240-2243, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31016745
18.
Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity.
J Am Acad Dermatol
; 71(6): 1160-6, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25199679
19.
Serum biomarker profiles suggest that atopic dermatitis is a systemic disease.
J Allergy Clin Immunol
; 141(4): 1523-1526, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29410314
20.
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).
Am J Clin Dermatol
; 25(3): 485-496, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38528257